Original Article

You have free access to this content

Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma†‡

  1. William F. Anderson MD, MPH1,§,*,
  2. Ruth M. Pfeiffer PhD1,
  3. Margaret A. Tucker MD2,
  4. Philip S. Rosenberg PhD1

Article first published online: 17 JUN 2009

DOI: 10.1002/cncr.24481

Issue

Cancer

Cancer

Volume 115, Issue 18, pages 4176–4185, 15 September 2009

Additional Information

How to Cite

Anderson, W. F., Pfeiffer, R. M., Tucker, M. A. and Rosenberg, P. S. (2009), Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer, 115: 4176–4185. doi: 10.1002/cncr.24481

Author Information

  1. 1

    Biostatistics Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Maryland

  2. 2

    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Maryland

  1. §

    Fax: (301) 402-0081

*Biostatistics Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, EPS, Room 8036, 6120 Executive Boulevard, Bethesda, MD 20892-7244

  1. †

    We thank the reviewers for helpful comments, which improved the content of this article.

  2. ‡

    This article is US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 4 SEP 2009
  2. Article first published online: 17 JUN 2009
  3. Manuscript Accepted: 5 FEB 2009
  4. Manuscript Revised: 2 FEB 2009
  5. Manuscript Received: 8 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (408K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. Stanganelli, G. Argenziano, F. Sera, A. Blum, F. Ozdemir, I.K. Karaarslan, D. Piccolo, K. Peris, H. Kirchesch, R. Bono, M.A. Pizzichetta, S. Gasparini, R.P. Braun, O. Correia, L. Thomas, P. Zaballos, S. Puig, J. Malvehy, M. Scalvenzi, H. Rabinovitz, A. Bergamo, G. Pellacani, C. Longo, M. Pavlovic, C. Rosendahl, R. Hofmann-Wellenhof, H. Cabo, A.A. Marghoob, D. Langford, S. Astorino, A.M. Manganoni, J.-Y. Gourhant, J. Keir, J.M. Grichnik, G. Fumo, H. Dong, A.M. Sortino Rachou, G. Ferrara, I. Zalaudek, Dermoscopy of scalp tumours: a multi-centre study conducted by the international dermoscopy society, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 6
    Direct Link:
  2. 2
    Friederike Erdmann, Joannie Lortet-Tieulent, Joachim Schüz, Hajo Zeeb, Rüdiger Greinert, Eckhard W. Breitbart, Freddie Bray, International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk?, International Journal of Cancer, 2012, 131, 3
    Direct Link:
  3. 3
    Kathrine Rugbjerg, Søren Friis, Christina Funch Lassen, Beate Ritz, Jørgen H. Olsen, Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease, International Journal of Cancer, 2012, 131, 3
    Direct Link:
  4. 4
    G. Nagel, T. Bjørge, T. Stocks, J. Manjer, G. Hallmans, M. Edlinger, C. Häggström, A. Engeland, D. Johansen, A. Kleiner, R. Selmer, H. Ulmer, S. Tretli, H. Jonsson, H. Concin, P. Stattin, A. Lukanova, Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can), British Journal of Dermatology, 2012, 166, 6
    Direct Link:
  5. 5
    Adèle C. Green, Victor Siskind, Risk factors for limb melanomas compared with trunk melanomas in Queensland, Melanoma Research, 2012, 22, 1, 86

    CrossRef

  6. 6
    Lutz Kretschmer, Hans Starz, Kai-Martin Thoms, Imke Satzger, Bernward Völker, Klaus Jung, Christina Mitteldorf, Claudia Bader, Katharina Siedlecki, Alexander Kapp, Hans Peter Bertsch, Ralf Gutzmer, Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma, International Journal of Cancer, 2011, 129, 6
    Direct Link:
  7. 7
    Andreas Stang, Jan Ivar Martinsen, Kristina Kjaerheim, Elisabete Weiderpass, Pär Sparén, Laufey Tryggvadóttir, Eero Pukkala, Cancer incidence among priests: 45 years of follow-up in four Nordic countries, European Journal of Epidemiology, 2011, 27, 2, 101

    CrossRef

  8. 8
    Anne E. Cust, Mark A. Jenkins, Chris Goumas, Bruce K. Armstrong, Helen Schmid, Joanne F. Aitken, Graham G. Giles, Richard F. Kefford, John L. Hopper, Graham J. Mann, Early-life sun exposure and risk of melanoma before age 40 years, Cancer Causes & Control, 2011, 22, 6, 885

    CrossRef

  9. 9
    Konstantinos G. Lasithiotakis, Athanasios Kokolakis, Elpida Giannikaki, Konstantinos Krasagakis, Androniki Tosca, Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic, Melanoma Research, 2011, 21, 5, 469

    CrossRef

  10. 10
    Hannah K. Weir, Loraine D. Marrett, Vilma Cokkinides, Jill Barnholtz-Sloan, Pragna Patel, Eric Tai, Ahmedin Jemal, Jun Li, Julian Kim, Donatus U. Ekwueme, Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006, Journal of the American Academy of Dermatology, 2011, 65, 5, S38.e1

    CrossRef

  11. 11
    Xiao-Cheng Wu, Melody J. Eide, Jessica King, Mona Saraiya, Youjie Huang, Charles Wiggins, Jill S. Barnholtz-Sloan, Nicolle Martin, Vilma Cokkinides, Jacqueline Miller, Pragna Patel, Donatus U. Ekwueme, Julian Kim, Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006, Journal of the American Academy of Dermatology, 2011, 65, 5, S26.e1

    CrossRef

  12. 12
    M.A. van der Aa, E. de Vries, H.J. Hoekstra, J.W.W. Coebergh, S. Siesling, Sociodemographic factors and incidence of melanoma in the Netherlands, 1994–2005, European Journal of Cancer, 2011, 47, 7, 1056

    CrossRef

  13. 13
    Beatriz Pérez-Gomez, Nuria Aragonés, Marina Pollan, Divergent cancer pathways for early onset and late onset cutaneous malignant melanoma, Cancer, 2010, 116, 10
    Direct Link:
  14. 14
    William F. Anderson, Margaret A. Tucker, Philip S. Rosenberg, Reply to Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma, Cancer, 2010, 116, 10
    Direct Link:
  15. 15
    David C Whiteman, Testing the divergent pathway hypothesis for melanoma: recent findings and future challenges, Expert Review of Anticancer Therapy, 2010, 10, 5, 615

    CrossRef

View Full Article (HTML) Get PDF (408K)